3x New Senior Medical Advisor vacancies in #oncology for a top pharmaceutical company. Contact Oliver Gould for more details.
Pharma Partners Recruitment Ltd’s Post
More Relevant Posts
-
#radiopharmaceuticals continue to be red hot and there seems to be no signs 2024 will be any different. According to data and analytics firm GlobalData, VC investments in the space rose from $63 million in 2017 to $408 million in 2023, year-to-date. With Lilly's acquisition of Point Biopharma and BMS acquiring RayzeBio, there is no doubt that the space has caught the eye of large pharma, joining Bayer and Novartis with their approved products already on the market. Prestige Scientific continues to be heavily involved and networked in theranostics space. Please reach out if we can be a resource here in 2024. #cmc #techops #radiopharma #theranostics #supplychain #prestigescientific #hiring #nuclearmedicine
We are excited to announce the successfully completed search for a Vice President of CMC with our partner, a clinical-stage pharmaceutical company focused on developing next-generation radiopharmaceutical therapies for cancer. This critical hire joins the leadership team early in the company's development. They will have the opportunity to build the CMC function from the ground up and shape the department as well as the overall strategy for the company. Prestige presented 22 candidates for this role, of which 15 were interviewed. Congratulations to our CMC and Technical Operations team for this successful search! #radiopharmaceuticals #biotechcareers #executivesearch #prestigescientific
-
-
Arecor Therapeutics plc (AIM:AREC) Chief Business Officer Manjit Rahelu speaks to Thomas Warner from Proactive after the #biopharmaceutical group announced a significant development from its Specialty Hospital division. A new collaboration with an unspecified "global medical products company" will focus on reformulating a blockbuster #oncology drug into a ready-to-use liquid form, enhancing its efficiency and ease of use for patients. This marks a significant shift from its powdered form, which was complex and time-consuming to prepare. The reconstituted drug is not only more convenient but also aims to reduce waiting times for patients, thereby improving overall healthcare delivery. Dr. Rahelu highlighted the collaborative effort involving a global partner with expertise in R&D, manufacturing, commercialisation, and regulatory affairs. This partnership aims to leverage both entities' strengths, combining Arecor's innovative in-house development with the partner's global capabilities. Arecor's technology has been instrumental in this advancement, underscoring their capability to apply their technology across various therapeutic areas beyond diabetes. This development is the second major outcome from Arecor's in-house pipeline and Rahelu says it demonstrates Arecor's ability to independently identify and develop promising candidates, translating R&D efforts into value-driving collaborations. Watch at #Proactive #ProactiveInvestors #AIM #AREC #ArecorTherapeutics #Arecor https://ow.ly/Gh0o50Qfo5k
Arecor Therapeutics reveals deal with "global medical products company"
https://www.youtube.com/
-
We're excited to share a fantastic testimonial from a TMF Project Client who achieved outstanding results with the help of our founder and leader Amy Longcore. This success story highlights Amy’s dedication to excellence and customer satisfaction that she instills in the Blue Parachute team projects. We take pride in rescuing neglected TMFs. Can we help you? #SafeLanding #BlueParachute #Testimonial #CustomerSuccess #ClientLove #ProudPartner #ExcellenceInService #Biotechnology #BioPharmaceutical #ClinicalDevelopment #ClinicalTrials #ClinicalOperations #Pharmaceutical #ClinicalResearch #Protocol #DrugDevelopment #ClinicalMonitoring #ClinicalDataManagement #RegulatoryAffairs #Oncology #Diabetes #Cardiovascular #ClinicalTrialEfficiency
-
-
#Announcement Trillioni Pharma achieves a new milestone! In line with our ongoing commitment to expanding pharmaceuticals to meet the diverse needs of our clients, we announce our strengthened presence in Germany through a new partnership with an EU GMP-certified manufacturer specialized in oncology products. With each new partnership, we enhance our role in streamlining communication between buyers and pharmaceutical manufacturers worldwide. Contact us for further inquiries and discuss your investment options. www.trillionipharma.com info@trillionipharma.com #Pharma #Trillioni #TrillioniPharma #TrillioniPlatform #TrillioniPharmaPlatform #PharmaceuticalManufacturing #Manufacturing #PharmaceuticalProducts #Medicine #Health #HealthCare #Germany #Partnership #GlobalNetWork #NewDeals #GMP #EU #Oncology #Oncological
-
-
We're thrilled to share this wonderful testimony from a TMF customer who experienced great results when she worked with our founder, Amy Longcore. This success story is a testament to Amy’s commitment to excellence and customer satisfaction. We love to rescue neglected TMFs. At Blue Parachute, we’ve got your back! #SafeLanding #Testimonial #CustomerSuccess #ClientLove #ProudPartner #ExcellenceInService #Biotechnology #BioPharmaceutical #ClinicalDevelopment #ClinicalTrials #ClinicalOperations #Pharmaceutical #ClinicalResearch #Protocol #DrugDevelopment #ClinicalMonitoring #ClinicalDataManagement #RegulatoryAffairs #Oncology #Diabetes #Cardiovascular #ClinicalTrialEfficiency
-
-
Key Insight Sharing: Pharmaceutical Industry Trends from 2023 to 2024 📊 R&D Companies by Region (2023-2024) ·U.S. companies decreased from 43% to 39%. ·Chinese companies continue to rise. 🔬 R&D Pipelines by Therapeutic Area ·Oncology: 9,142 drugs, up 7.8%. ·Neurological: 7.5% growth. ·Digestive/Metabolic: 13.1% growth. ·Anti-infective: Only 0.8% growth. 🧪 Clinical Trials by Therapeutic Area (2024) ·Oncology trials: 18,966, up 7.7%. Stay tuned for more industry insights! #Pharmaceuticals #Oncology #ClinicalTrials #Innovation #Healthcare
-
-
Vividion Therapeutics, Inc. to Expand with New Global R&D Center The San Diego facility will support further developing Vividion's global research and clinical portfolio and pave the way for future programs to deliver best-in-class #therapeutics to patients. Vividion, a clinical-stage #biopharmaceutical company, recently announced it will expand its global #innovation capabilities with a new research and development (R&D) center and corporate headquarters in San Diego, California. Vividion is a wholly owned and independently operating subsidiary of Bayer. The new facility will significantly increase the company’s chemoproteomics screening capacity. More than half of the expansion will be dedicated to state-of-the-art research labs. It will accommodate strategic growth capabilities and continue to attract and retain top life sciences experts in San Diego, a rapidly growing hub for #biotech innovation. “Vividion has entered an exciting new stage in the company’s development, with multiple programs in clinical trials, a rich discovery portfolio and expansive platform screening efforts focused on bringing more previously undrugged disease-causing targets within the reach of small molecule therapeutics. Our new R&D center and headquarters will provide the infrastructure to execute our strategic vision and continue to lead the way in applying #chemoproteomics and covalent chemistry to create first-in-class medicines for patients in need,” said Aleksandra Rizo, Chief Executive Officer of Vividion. Read more on #CMI online:
-
-
Join us for a (free) webinar on the crucial role of gathering quality data to ensure FDA approval and payer reimbursement that will be hosted by Clinical Leader. One of the speakers, Amy Longcore, founder of Blue Parachute, will share some of her stories on how to run efficient trials (and some things NOT to do). She will be presenting alongside Medrio’s CEO Nicole DuPont Latimer. Don't miss out! #SafeLanding #Webinar #ProfessionalDevelopment #IndustryInsights #Networking #Learning #Biotechnology #BioPharmaceutical #ClincialDevelopment #ClinicalTrials #ClinicalOperations #Pharmaceutical #ClinicalResearch #Protocol #DrugDevelopment #ClinicalMonitoring #ClinicalDataManagement #RegulatoryAffairs #Oncology #Diabetes #Cardiovascular #ClinicalTrialEfficiency
-
-
Does your TMF capture all of the expected clinical trial documents? If you aren’t sure, contact us at help@blueparachute.com for a free consultation. Once hired, Amy Longcore and her team will help your Trial Master File achieve a #SafeLanding. At Blue Parachute, we've got your back! #Biotechnology #BioPharmaceutical #ClinicalDevelopment #ClinicalTrials #ClinicalOperations #Pharmaceutical #ClinicalResearch #Protocol #DrugDevelopment #ClinicalMonitoring #ClinicalDataManagement #RegulatoryAffairs #Oncology #Diabetes #Cardiovascular #ClinicalTrialEfficiency
-
